Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up
With Covid-19 contract work growing at a rapid clip, the biggest CDMOs are taking the opportunity — and a windfall of cash — to carve out bigger footprints. At Thermo Fisher Scientific, the time’s never been better for a farsighted global expansion that will greatly expand its manufacturing capacity and add redundancy to the supply chain.
Thermo will pump $600 million into its global manufacturing network as part of a move to ramp up its short-term Covid-19 work and more than double its capacity for the future, the Massachusetts firm said Wednesday.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
